Vice President, Bioanalytical Services
Celerion
Lincoln, Nebraska
With 30 years of experience in the pharmaceutical industry, Jo Goodman has a wealth of knowledge in drug development, regulated GxP and discovery bioanalysis for both in-house and outsourced activities. She has particular expertise in PK, Biomarkers/PD and immunogenicity for a range of drug modalities at all stages of drug development, as well as authoring global bioanalytical regulatory submissions. In her current role, Jo leads the Celerion Bioanalytical team in Lincoln, Nebraska as the Vice President for Bioanalytical Services. Prior to joining Celerion, she held positions of increasing responsibility at AstraZeneca, MedImmune, and GlaxoSmithKline. Jo recently served as a member of the Expert Working Group (EWG) for ICH M10 Bioanalytical Guidance Development representing the European Federation of Pharmaceutical Industries and Associations (EFPIA), was a member of the European Bioanalysis Forum (EBF) Steering Committee and Board of Directors and was active in other industry consortia such as American Association of Pharmaceutics Scientists (AAPS), European Immunogenicity Platform (EIP) and Drug Metabolism Discussion Group (DMDG).
Disclosure information not submitted.
Rapid Fires: Current Challenges in Bioanalytical Labs 2
Tuesday, October 22, 2024
3:00 PM – 4:00 PM MT